Whole-genome sequencing in triple-negative #breastcancer supports the prognostic value of the HRDetect algorithm for improving patient stratification in a real-world clinical diagnostic setting #NMEDClinical #BreastCancerAwarenessMonth |
Whole-genome sequencing of triple-negative #breastcancer in a population-based clinical study reveals novel mechanism of BRCA1 abrogation and enables assignment of pts HRD status: #bcsm
Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study Congrats
Population-based WGS of triple negative breast cancers in the clinical setting. By and colleagues in
Whole-genome sequencing in triple-negative #breastcancer supports the prognostic value of the HRDetect mutational-signature-based algorithm for improving patient stratification in a real-world, population-based clinical diagnostic setting #NMEDClinical |
Whole-genome sequencing is providing new insights into triple-negative breast cancer: A population-based study. Via
That was the 1st of a 3-fer on WGS for #cancer today Value of whole genome sequencing for 254 patients w/ triple-negative breast cancer by and collaborators
Our #SCANB #WGS of #TNBC study featured by ⁦⁩ 14:51 onwards! #GetTheWHOLEPicture #BreastCancerAwarenessMonth
Three new papers today on how genomic profiling can help better inform trial stratification and improve clinical decision-making in oncology SCAN-B Tempus Dutch "Drug Rediscovery" protocol